Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1578154-21-8

(3S)-4-[[(4R)-4-(2-chloro-4-fluoro-phenyl)-2-thiazol-2-yl-5-(2,2,2-trifluoroethoxycarbonyl)-1,4-dihydropyrimidin-6-yl]methyl]-morpholine-3-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1578154-21-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1578154-21-8 Structure

  • Basic information

    1. Product Name: (3S)-4-[[(4R)-4-(2-chloro-4-fluoro-phenyl)-2-thiazol-2-yl-5-(2,2,2-trifluoroethoxycarbonyl)-1,4-dihydropyrimidin-6-yl]methyl]-morpholine-3-carboxylic acid
    2. Synonyms:
    3. CAS NO:1578154-21-8
    4. Molecular Formula:
    5. Molecular Weight: 562.929
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1578154-21-8.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: (3S)-4-[[(4R)-4-(2-chloro-4-fluoro-phenyl)-2-thiazol-2-yl-5-(2,2,2-trifluoroethoxycarbonyl)-1,4-dihydropyrimidin-6-yl]methyl]-morpholine-3-carboxylic acid(CAS DataBase Reference)
    10. NIST Chemistry Reference: (3S)-4-[[(4R)-4-(2-chloro-4-fluoro-phenyl)-2-thiazol-2-yl-5-(2,2,2-trifluoroethoxycarbonyl)-1,4-dihydropyrimidin-6-yl]methyl]-morpholine-3-carboxylic acid(1578154-21-8)
    11. EPA Substance Registry System: (3S)-4-[[(4R)-4-(2-chloro-4-fluoro-phenyl)-2-thiazol-2-yl-5-(2,2,2-trifluoroethoxycarbonyl)-1,4-dihydropyrimidin-6-yl]methyl]-morpholine-3-carboxylic acid(1578154-21-8)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1578154-21-8(Hazardous Substances Data)

1578154-21-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1578154-21-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,7,8,1,5 and 4 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1578154-21:
(9*1)+(8*5)+(7*7)+(6*8)+(5*1)+(4*5)+(3*4)+(2*2)+(1*1)=188
188 % 10 = 8
So 1578154-21-8 is a valid CAS Registry Number.

1578154-21-8Downstream Products

1578154-21-8Relevant articles and documents

Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors

Qiu, Zongxing,Lin, Xianfeng,Zhang, Weixing,Zhou, Mingwei,Guo, Lei,Kocer, Buelent,Wu, Guolong,Zhang, Zhisen,Liu, Haixia,Shi, Houguang,Kou, Buyu,Hu, Taishan,Hu, Yimin,Huang, Mengwei,Yan, S. Frank,Xu, Zhiheng,Zhou, Zheng,Qin, Ning,Wang, Yue Fen,Ren, Shuang,Qiu, Hongxia,Zhang, Yuxia,Zhang, Yi,Wu, Xiaoyue,Sun, Kai,Zhong, Sheng,Xie, Jianxun,Ottaviani, Giorgio,Zhou, Yuan,Zhu, Lina,Tian, Xiaojun,Shi, Liping,Shen, Fang,Mao, Yi,Zhou, Xue,Gao, Lu,Young, John A. T.,Wu, Jim Zhen,Yang, Guang,Mayweg, Alexander V.,Shen, Hong C.,Tang, Guozhi,Zhu, Wei

, p. 3352 - 3371 (2017/05/05)

Described herein are the discovery and structure-activity relationship (SAR) studies of the third-generation 4-H heteroaryldihydropyrimidines (4-H HAPs) featuring the introduction of a C6 carboxyl group as novel HBV capsid inhibitors. This new series of 4-H HAPs showed improved anti-HBV activity and better drug-like properties compared to the first- and second-generation 4-H HAPs. X-ray crystallographic study of analogue 12 (HAP_R01) with Cp149 Y132A mutant hexamer clearly elucidated the role of C6 carboxyl group played for the increased binding affinity, which formed strong hydrogen bonding interactions with capsid protein and coordinated waters. The representative analogue 10 (HAP_R10) was extensively characterized in vitro (ADMET) and in vivo (mouse PK and PD) and subsequently selected for further development as oral anti-HBV infection agent.

6-AMINO ACID HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

-

Page/Page column 93; 113, (2014/03/26)

The invention provides novel compounds having the general formula:, wherein R1, R2, R3, R4 and A are as described herein, compositions including the compounds and methods of using the compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1578154-21-8